Skip to main content

Table 2 Observed and expected numbers of complications in six NTCP groups

From: Modeling of α/β for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer

NTCP range No. of patients Observed Complications Expected Complications
0.05-0.075 11 2 1
0.075-0.10 19 3 2
0.10-0.125 18 3 2
0.125-0.15 25 2 4
0.15-0.175 27 4 4
0.175-0.25 15 1 3